What is the absolute neutrophil count (ANC) on a complete blood count (CBC), how is it calculated, and what are its normal values and clinical significance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Absolute Neutrophil Count (ANC) on CBC

The absolute neutrophil count (ANC) is calculated by multiplying the total white blood cell (WBC) count by the percentage of neutrophils (segmented neutrophils + bands), with normal values typically 1.5-8.0 × 10³/µL in Caucasian adults, though this threshold must be adjusted to 1.0 × 10³/µL for individuals of African or Middle Eastern ancestry with Duffy-null phenotype.

Calculation Method

The ANC is derived from the CBC using this formula:

ANC = WBC count × (% neutrophils + % bands) ÷ 100

For example, if WBC = 6.0 × 10³/µL with 60% segmented neutrophils and 5% bands:

  • ANC = 6.0 × (60 + 5) ÷ 100 = 3.9 × 10³/µL

The calculation combines mature neutrophils (segmented forms) with immature neutrophils (band forms) to give the total absolute phagocyte count 1.

Normal Values and Ethnic Considerations

Standard reference ranges:

  • Caucasian adults: 1.8-8.0 × 10³/µL (WHO threshold) 2
  • General population: 1.5-8.0 × 10³/µL 2, 3

Critical adjustment for Duffy-null individuals:

Individuals with the Duffy-null phenotype [Fy(a-b-)], predominantly those of African and Middle Eastern ancestry, have physiologically lower neutrophil counts without increased infection risk. For these patients 4:

  • WBC reference: 2.43-7.05 × 10³/µL
  • ANC reference: 1.01-4.34 × 10³/µL
  • Median ANC: 1.45 × 10³/µL (versus 4.45 × 10³/µL in general population)

This is not pathologic neutropenia but a benign ethnic variant that should not trigger unnecessary interventions, dose reductions, or treatment delays 5.

Clinical Significance by Severity

Neutropenia classification:

  • Mild neutropenia: ANC 1.0-1.5 × 10³/µL

    • Minimal infection risk in most patients
    • For Duffy-null individuals, this is often normal baseline 4

  • Moderate neutropenia: ANC 0.5-1.0 × 10³/µL

    • Increased infection susceptibility
    • Requires clinical context for management decisions

  • Severe neutropenia: ANC <0.5 × 10³/µL

    • High infection risk requiring intervention 2, 3

  • Profound neutropenia: ANC <0.1 × 10³/µL

    • Highest infection risk; fluoroquinolone prophylaxis indicated if expected >7 days 1, 6

Clinical Applications in Cancer Treatment

Chemotherapy management thresholds:

In neutropenic cancer patients, ANC guides critical treatment decisions 1, 7:

  • ANC >500/mm³: Generally safe to continue or restart chemotherapy
  • ANC <500/mm³: Defines neutropenia requiring empiric broad-spectrum antibiotics if febrile
  • ANC <100/mm³ for >7 days: High-risk category requiring fluoroquinolone prophylaxis 1, 6

For patients with Duffy-null phenotype receiving cancer treatment, standard ANC thresholds may inappropriately delay chemotherapy or trigger unnecessary G-CSF use 5. These patients should be managed using Duffy-null-specific reference ranges.

Monitoring Frequency

For clozapine treatment (where severe neutropenia risk exists) 8:

  • Weekly ANC monitoring for first 18 weeks
  • Every 4 weeks after 18 weeks through 2 years
  • Can cease ANC monitoring after 2 years if stable
  • Cessation threshold: ANC <1.0 × 10⁹/L (or <0.5 × 10⁹/L for Duffy-null individuals)

For cancer patients with neutropenia 1:

  • Daily monitoring during febrile neutropenia
  • Monitor for marrow recovery indicators: daily increases in absolute phagocyte count, monocyte count, or reticulocyte fraction often precede ANC reaching 500/mm³ by several days

Common Pitfalls to Avoid

  1. Misclassifying Duffy-null individuals as neutropenic: Always check ethnicity and consider Duffy phenotyping in patients of African or Middle Eastern ancestry with persistently low ANC but no infections 4, 5

  2. Ignoring band forms in calculation: The ANC must include both segmented neutrophils AND bands for accurate assessment 1

  3. Using fever pattern alone to modify antibiotics: In neutropenic patients on empiric antibiotics, persistent fever without clinical deterioration rarely requires regimen changes; median time to defervescence is 5 days in hematologic malignancies 1

  4. Premature antibiotic discontinuation: In high-risk patients, continue antibiotics until ANC >500/mm³ AND resolution of fever, not based on time alone 1

References

Related Questions

A 3-year-old child has a CBC with a white blood cell count of 4.3 × 10³/µL and a neutrophil percentage of 0.67 %. What is the absolute neutrophil count (ANC)?
What is the appropriate evaluation and management for an 11‑year‑old female with an absolute neutrophil count of 1,415 cells/µL, total white‑blood‑cell count of 4.2 ×10⁹/L, HDL cholesterol of 38 mg/dL, hemoglobin A1c of 5.9%, weight 80 lb, and height 5′2″?
In an 11-year-old female with borderline neutropenia and a low‑normal white blood cell count, what is the appropriate management?
What is the appropriate workup for an asymptomatic 35-year-old African-American male with leukopenia (white blood cell count 3.01 × 10^3/µL and absolute neutrophil count 2.75 × 10^3/µL)?
In a 61‑year‑old woman with mild leukopenia (white blood cell count 3.8 K/µL) due to neutropenia (absolute neutrophil count 1.3 ×10^3/µL) and relative lymphocytosis, and a mild normocytic‑normochromic anemia (hemoglobin 11.1 g/dL, hematocrit 35.9 %), what is the appropriate interpretation and recommended diagnostic work‑up?
Having used the Mirena (levonorgestrel-releasing intrauterine device) since [date] and approaching five years of use, does it increase my risk of cancer?
Does worsening renal function increase the INR in patients taking Sintrom (acenocoumarol)?
What is the appropriate dosing regimen of retatrutide for weight loss in an adult patient with obesity (BMI ≥ 30 kg/m²) without contraindications?
What are the indications and contraindications for imiquimod 5% cream?
What is the appropriate management for a serum 25‑hydroxyvitamin D level of 8.31 ng/mL?
In a 74-year-old woman with five days of severe facial and dental pain, right-sided facial swelling extending into the neck with erythema and palpable cervical lymphadenopathy, what are the differential diagnoses?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.